Indirect Pulp Capping With Biodentine and TheraCal LC in Permanent Mature Molars
Primary Purpose
Deep Carious Lesions, Reversible Pulpitis, Indirect Pulp Capping
Status
Unknown status
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Indirect pulp capping
Sponsored by
About this trial
This is an interventional treatment trial for Deep Carious Lesions focused on measuring permanent molars, indirect pulp capping, reversible pulpitis, deep carious lesions, Biodentine, TheraCal LC
Eligibility Criteria
Inclusion Criteria:
- Patient ≥ 18 years without any systemic disease.
- Presence of a deep carious lesion in a permanent mature molar without periapical pathology that penetrates radiographically into the inner dentin half or even third/ quarter.
- Preoperative diagnosis of reversible pulpitis.
- After selective caries removal to soft dentin with a high-speed diamond bur and Cariosolv gel and hand instruments, no pulpal exposure occurred.
Exclusion Criteria:
- Negative response to pulp sensibility tests.
- Clinical symptoms of irreversible pulpitis or pulp necrosis.
- Presence of fistula, swelling, tenderness to percussion, tooth mobility.
- Presence of periapical pathology on periapical radiographs (internal or external root resorption, abscence of normal appearance of periodontal ligament, presence of interradicular or periapical radiolucencies).
- Pregnant women.
Sites / Locations
- University of ValenciaRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Biodentine
TheraCal LC
Arm Description
Indirect pulp capping with Biodentine in mature permanent molars with deep carious lesions and reversible pulpitis
Indirect pulp capping with TheraCal LC in mature permanent molars with deep carious lesions and reversible pulpitis
Outcomes
Primary Outcome Measures
response to pulp sensibility testing ( thermal and electric pulp testing)
abscence of clinical signs and/or symptoms and radiographic findings of pulp degeneration
Secondary Outcome Measures
Full Information
NCT ID
NCT03741816
First Posted
November 12, 2018
Last Updated
January 6, 2019
Sponsor
University of Valencia
1. Study Identification
Unique Protocol Identification Number
NCT03741816
Brief Title
Indirect Pulp Capping With Biodentine and TheraCal LC in Permanent Mature Molars
Official Title
Randomized Blind Clinical Trial, Two-armed, Parallel of Indirect Pulp Capping With Biodentine and TheraCal LC in Permanent Mature Molars With Deep Carious Lesions
Study Type
Interventional
2. Study Status
Record Verification Date
January 2019
Overall Recruitment Status
Unknown status
Study Start Date
January 7, 2019 (Actual)
Primary Completion Date
January 2020 (Anticipated)
Study Completion Date
January 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Valencia
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Management of deep carious lesions in permanent mature molars with reversible pulpitis represents a challenge for clinicians. Vital pulp therapy includes indirect and direct pulp capping, partial pulpotomy and full pulpotomy. Indirect pulp capping is a procedure in which a material is placed on a thin layer of remaining soft dentin that, if removed, might expose the pulp. The objective is dentin bridge formation and pulp vitality preservation.
The aim of this randomized clinical trial is to evaluate the success rate of indirect pulp capping with Biodentine and TheraCal LC in mature permanent molars with deep carious lesions at one-year follow-up examination. The null hypothesis tested will be that there is no statistically significant difference in success rate between both materials in indirect pulp capping of permanent mature molars with deep carious lesions.
Detailed Description
Treatment options for permanent mature molars with deep carious lesions and a preoperative diagnosis of reversible pulpitis are varied among clinicians. In the last few years, a more biological approach is arising interest in the field of Endodontics through the development of calcium-silicate based cements that are used in vital pulp therapy.
A great variety of materials have been employed for indirect pulp capping. Although calcium hydroxide has been the "gold standard" for decades for this procedure, nowadays calcium-silicate based cements such as Mineral Trioxide Aggregate (MTA) are preferred. The second generation of these cements, among which Biodentine (Septodont, Saint Maur-des-Fossés, France) and TheraCal LC (Bisco, Schaumburg, IL, USA) stand out, try to overcome the first generation limitations.
On the other hand, there is a paradigm shift in caries removal techniques. Nowadays, the non-selective technique is not longer recommended and a selective removal technique until soft dentin is preferred in deep cavitated lesions.
The study will be carried out at the dental clinic of the Master of Restorative Dentistry and Endodontics (Medical and Dental School) of University of Valencia (Spain).
The study protocol that will be followed is:
Sample size estimation: 212 participants (106 per group).
Informed written consent will be obtained from all participants.
A full dental and medical history will be obtained from all patients.
Clinical (thermal and electric pulp tests, and palpation and percussion) and a radiographic examination (periapical radiograph and a small-volume cone beam computed tomography (CBCT).
Anesthesia administration and rubber dam placement.
Selective caries removal technique with high-speed diamond burs with air/water spray for enamel and Cariosolv gel and hand instruments until soft dentin.
Allocation to one of the two groups: Biodentine (control) or TheraCal LC (experimental) for indirect pulp capping procedures.
Final direct composite restoration using the selective etching technique and an universal adhesive.
Baseline periapical radiograph.
Follow-up: clinical and radiographic follow-up examinations will be conducted at one month, six months and twelve months (±2 weeks). In the one-year follow-up examination, a small-volume CBCT will be taken.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Deep Carious Lesions, Reversible Pulpitis, Indirect Pulp Capping
Keywords
permanent molars, indirect pulp capping, reversible pulpitis, deep carious lesions, Biodentine, TheraCal LC
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
212 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Biodentine
Arm Type
Active Comparator
Arm Description
Indirect pulp capping with Biodentine in mature permanent molars with deep carious lesions and reversible pulpitis
Arm Title
TheraCal LC
Arm Type
Experimental
Arm Description
Indirect pulp capping with TheraCal LC in mature permanent molars with deep carious lesions and reversible pulpitis
Intervention Type
Drug
Intervention Name(s)
Indirect pulp capping
Intervention Description
Indirect pulp capping is a procedure in which a material is placed on a thin partition of remaining carious dentin that, if removed might expose the pulp.
Primary Outcome Measure Information:
Title
response to pulp sensibility testing ( thermal and electric pulp testing)
Description
abscence of clinical signs and/or symptoms and radiographic findings of pulp degeneration
Time Frame
one year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient ≥ 18 years without any systemic disease.
Presence of a deep carious lesion in a permanent mature molar without periapical pathology that penetrates radiographically into the inner dentin half or even third/ quarter.
Preoperative diagnosis of reversible pulpitis.
After selective caries removal to soft dentin with a high-speed diamond bur and Cariosolv gel and hand instruments, no pulpal exposure occurred.
Exclusion Criteria:
Negative response to pulp sensibility tests.
Clinical symptoms of irreversible pulpitis or pulp necrosis.
Presence of fistula, swelling, tenderness to percussion, tooth mobility.
Presence of periapical pathology on periapical radiographs (internal or external root resorption, abscence of normal appearance of periodontal ligament, presence of interradicular or periapical radiolucencies).
Pregnant women.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Cristina Pasarín Linares
Phone
+ 34 630493515
Email
cpasarinlinares@gmail.com
Facility Information:
Facility Name
University of Valencia
City
Valencia
Country
Spain
Individual Site Status
Recruiting
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Indirect Pulp Capping With Biodentine and TheraCal LC in Permanent Mature Molars
We'll reach out to this number within 24 hrs